These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12482437)

  • 1. Discovery of a series of (4,5-dihydroimidazol-2-yl)-biphenylamine 5-HT7 agonists.
    Parikh V; Welch WM; Schmidt AW
    Bioorg Med Chem Lett; 2003 Jan; 13(2):269-71. PubMed ID: 12482437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel aminoethylbiphenyls as 5-HT7 receptor ligands.
    Paillet-Loilier M; Fabis F; Lepailleur A; Bureau R; Butt-Gueulle S; Dauphin F; Lesnard A; Delarue C; Vaudry H; Rault S
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3018-22. PubMed ID: 17419056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-basicity 5-HT
    Hogendorf AS; Hogendorf A; Kurczab R; Satała G; Lenda T; Walczak M; Latacz G; Handzlik J; Kieć-Kononowicz K; Wierońska JM; Woźniak M; Cieślik P; Bugno R; Staroń J; Bojarski AJ
    Sci Rep; 2017 May; 7(1):1444. PubMed ID: 28473721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor.
    Kikuchi C; Ando T; Watanabe T; Nagaso H; Okuno M; Hiranuma T; Koyama M
    J Med Chem; 2002 May; 45(11):2197-206. PubMed ID: 12014957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
    Campiani G; Morelli E; Gemma S; Nacci V; Butini S; Hamon M; Novellino E; Greco G; Cagnotto A; Goegan M; Cervo L; Dalla Valle F; Fracasso C; Caccia S; Mennini T
    J Med Chem; 1999 Oct; 42(21):4362-79. PubMed ID: 10543880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel 2-oxo-1,2-dihydro-3-quinolinecarboxamide derivatives as potent and selective serotonin 5-HT4 receptor agonists.
    Suzuki M; Ohuchi Y; Asanuma H; Kaneko T; Yokomori S; Ito C; Isobe Y; Muramatsu M
    Chem Pharm Bull (Tokyo); 2001 Jan; 49(1):29-39. PubMed ID: 11201221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
    Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
    J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation.
    Imanishi N; Iwaoka K; Koshio H; Nagashima SY; Kazuta K; Ohta M; Sakamoto S; Ito H; Akuzawa S; Kiso T; Tsukamoto S; Mase T
    Bioorg Med Chem; 2003 Apr; 11(7):1493-502. PubMed ID: 12628674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
    Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE
    J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.
    Filla SA; Mathes BM; Johnson KW; Phebus LA; Cohen ML; Nelson DL; Zgombick JM; Erickson JA; Schenck KW; Wainscott DB; Branchek TA; Schaus JM
    J Med Chem; 2003 Jul; 46(14):3060-71. PubMed ID: 12825944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy.
    Xu YC; Johnson KW; Phebus LA; Cohen M; Nelson DL; Schenck K; Walker CD; Fritz JE; Kaldor SW; LeTourneau ME; Murff RE; Zgombick JM; Calligaro DO; Audia JE; Schaus JM
    J Med Chem; 2001 Nov; 44(24):4031-4. PubMed ID: 11708905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.
    Assié MB; Cosi C; Koek W
    Eur J Pharmacol; 1999 Dec; 386(1):97-103. PubMed ID: 10611469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists.
    Leung E; Pulido-Rios MT; Bonhaus DW; Pekins LA; Zeitung KD; Hsu SA; Clark RD; Wong EH; Eglen RM
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):145-56. PubMed ID: 8857591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-[[1-(2-phenylethyl)pyrrolidin-2-yl]methyl]cyclohexanecarboxamides as selective 5-HT1A receptor agonists.
    Fujio M; Togo Y; Tomozane H; Kuroita T; Morio Y; Katayama J; Matsumoto Y
    Bioorg Med Chem Lett; 2000 Mar; 10(5):509-12. PubMed ID: 10743959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 5-hydroxytryptamine 4 (5-HT4) receptor agonists. Synthesis and gastroprokinetic activity of 4-amino-N-[2-(1-aminocycloalkan-1-yl)ethyl]-5-chloro-2-methoxybenzamide s.
    Suzuki T; Imanishi N; Itahana H; Watanuki S; Miyata K; Ohta M; Nakahara H; Yamagiwa Y; Mase T
    Chem Pharm Bull (Tokyo); 1998 Jul; 46(7):1116-24. PubMed ID: 9692218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT(2A/2C) receptor agonists.
    Chambers JJ; Kurrasch-Orbaugh DM; Parker MA; Nichols DE
    J Med Chem; 2001 Mar; 44(6):1003-10. PubMed ID: 11300881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
    Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
    J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
    Hedlund PB; Kelly L; Mazur C; Lovenberg T; Sutcliffe JG; Bonaventure P
    Eur J Pharmacol; 2004 Mar; 487(1-3):125-32. PubMed ID: 15033384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.
    Glennon RA; Lee M; Rangisetty JB; Dukat M; Roth BL; Savage JE; McBride A; Rauser L; Hufeisen S; Lee DK
    J Med Chem; 2000 Mar; 43(5):1011-8. PubMed ID: 10715164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Substituted (2,3-dihydro-1,4-benzodioxin-2-yl)methylamine derivatives as D(2) antagonists/5-HT(1A) partial agonists with potential as atypical antipsychotic agents.
    Birch AM; Bradley PA; Gill JC; Kerrigan F; Needham PL
    J Med Chem; 1999 Aug; 42(17):3342-55. PubMed ID: 10464021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.